FDA Inspection 1149848 — Nathan Segall, MD, CPI
The FDA completed an inspection of Nathan Segall, MD, CPI on August 13, 2021 in Stockbridge, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 13, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Stockbridge, GA (United States)
Additional Details
Clinical Investigator (CI)